Risk of Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatohepatitis: A Retrospective Cohort Study
Patients with T2D and MASH had higher hazards of microvascular and macrovascular complications versus those with T2D without MASH. These findings suggest that the presence of MASH accelerates T2D-related complications, creating a clinical imperative for integrated screening and management approaches to identify this high-risk population among patients with T2D.
Authors
- Anthony Hoovler (ORCID: https://orcid.org/0000-0002-8833-4923)
- Caichen Zhong (ORCID: https://orcid.org/0000-0002-1442-4133)
- Husam Albarmawi (ORCID: https://orcid.org/0000-0001-8870-0842)
- Semiu O. Gbadamosi (ORCID: https://orcid.org/0000-0003-2048-2943)
- Carlos Eduardo Campos (ORCID: https://orcid.org/0000-0001-9794-8487)
- AP McGovern
- Abdalla Aly
- David Shi
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- Novo Nordisk (United States) (US)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1007/s13300-025-01831-7
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk